SelectScience Limited has announced two key developments as it accelerates its growth as a world-leading digital science publisher.
From its HQ in Corston, Bath, SelectScience provides vital online information to scientists around the world at the forefront of cancer research, the fight against COVID-19 and many other critical scientific fields.
Today, building on a period of exceptional growth, the company has stepped up its mission to make the future healthier by announcing Vespa Capital as new investment partners and Kerry Parker as its new CEO.
Kerry, who has lived in Bath since she started work at SelectScience as an editorial assistant 15 years ago, steps up to the new role from her previous position as Publisher and Editor-in-Chief. She is one of around 30 local employees currently working for the fast-growing company, which is actively recruiting for roles across its marketing, editorial, finance and sales teams despite the pandemic.
“I am delighted to be working alongside our management team and Vespa Capital partners in order to amplify our plans, whilst continuing with our overarching mission to make the world a healthier place,” said Kerry.
SelectScience was founded in 1998 by Arif Butt and Louise Butt, with a vision to introduce peer-to-peer and digital marketing services into the scientific industry. The business has subsequently established an enviable market position, serving high-quality digital marketing solutions to the industry, including the world’s top 10 manufacturers of scientific laboratory equipment. In addition, SelectScience has developed an extensive and expanding global audience of loyal members, who are attracted to the company’s engaging digital content such as The Scientists’ Channel, virtual events, and more.
Arif and Louise Butt, also from Bath, said: “We are delighted to announce this important news. Kerry Parker has already been leading the impressive growth alongside our management team, and, partnering with the impressive private equity company Vespa Capital, we are excited to see immense further growth of the company. In retiring our current positions, we are pleased to continue to support SelectScience’s success as shareholders and ambassadors.”
Matt Lyons, Partner at Vespa Capital, said: “We’re delighted to join SelectScience as investment partners and are excited by the opportunity to work with Kerry and the team as they continue to build a world-class digital publishing platform servicing an attractive and niche customer group. The Vespa Capital portfolio already includes businesses in the pharmaceutical, digital and product reviews industries, including those supporting the fight against the COVID-19 pandemic.”